Vaccination status and disease severity of COVID-19 in different phases of the pandemic-Reference-Cited by-同舟云学术

Vaccination status and disease severity of COVID-19 in different phases of the pandemic

Published:2024-06-04 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Yang Xueying¹²,Shi Fanghui¹²^ORCID,Zhang Jiajia¹³,Gao Haoyuan¹³,Chen Shujie¹³,Olatosi Bankole¹⁴,Weissman Sharon¹⁵,Li Xiaoming¹²

Affiliation:

1. South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA

2. Department of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA

3. Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA

4. Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA

5. Department of Internal Medicine, School of Medicine, University of South Carolina, Columbia, SC, USA

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2353491

Reference42 articles.

1. Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings;Faria NR;Virological,2021

2. European Centre for Disease Prevention and Control. SARS-CoV-2 variants of concern as of 26 August 2021. 2021 [accessed 2022 Jul 5]. https://www.ecdc.europa.eu/en/covid-19/variants-concern.

3. Changing Epidemiology of SARS-CoV in the Context of COVID-19 Pandemic

4. Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: Perspectives for public health

5. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study